Skip to main content
SpringerLink
Log in

Tripmiddelen: lsd en psychedelische paddenstoelen

  • Chapter
Drugs en alcohol; Gebruik, misbruik en verslaving

  • 7036 Accesses

Psychedelische paddenstoelen worden al duizenden jaren gebruikt door de mensheid. In grotten op het Tassiliplateau in Algerije zijn spectaculaire rotstekeningen teruggevonden van minstens 5500 jaar oud. De bekendste beeldt een man uit met een bijenhoofd en paddenstoelen groeiend op het hele lichaam.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Referenties

  • Abraham HD, Aldridge AM. Adverse consequences of lysergic acid diethylamide. Addiction 1993; 88(10): 1327–1334.

    Article  PubMed  CAS  Google Scholar 

  • Abraham MD, Cohen PDA, Kaal HL. Licit and illicit drug use in the Netherlands, 2001. Amsterdam: Mets; 2002.

    Google Scholar 

  • Abraham HD, Aldridge AM, Gogia P. The psychopharmacology of hallucinogens. Neuropsychopharmacology 1996; 14(4): 285–298.

    Article  PubMed  CAS  Google Scholar 

  • Bogers H, Snelders S, Plomp H. De psychedelische (r)evolutie. Amsterdam: Bres; 1993.

    Google Scholar 

  • Brown D. Psychedelic healing? Hallucinogenic drugs, which blew minds in the 1960s, soon may be used to treat mental ailments. Scientifi c American Mind 2007; Dec 2007/Jan 2008: 66–71.

    Google Scholar 

  • Buster M, Brussel G. van. Acute medische hulp in verband met incidenten door het gebruik van roesmiddelen in Amsterdam. Een stijgende trend van paddo-incidenten. Amsterdam: GGD; 2007.

    Google Scholar 

  • Calvino J. et al. Voluntary ingestion of Cortinarius mushrooms leading to chronic interstitial nephritis. Am J Nephrol 1998; 18(6): 565–569.

    Article  PubMed  CAS  Google Scholar 

  • Carter OL. et al. Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. J Cogn Neurosci 2005; 17(10): 1497–1508.

    Article  PubMed  Google Scholar 

  • Colpaert FC. Discovering risperidone: the LSD model of psychopathology. Nat Rev Drug Discov 2003; 2(4): 315–320.

    Article  PubMed  CAS  Google Scholar 

  • Coördinatiepunt Assessment en Monitoring nieuwe drugs (CAM). Risicoschatting van psilocine en psilocybine bevattende paddenstoelen (paddo's). Bilthoven; 2007.

    Google Scholar 

  • Dart R. Medical Toxicology. Lippincott: Williams & Wilkins; 2003.

    Google Scholar 

  • Drug Enforcement Administration (DEA). LSD in de United States. US Department of Justice; 1995.

    Google Scholar 

  • Dyck E. Flashback: psychiatric experimentation with LSD in historical perspective. Can J Psychiatry 2005; 50(7): 381–388.

    PubMed  Google Scholar 

  • Espiard ML. et al. Hallucinogen persisting perception disorder after psilocybin consumption: a case study. Eur Psychiatry 2005; 20(5-6): 458–460.

    Article  PubMed  Google Scholar 

  • Fantegrossi WE, Woods JH, Winger G. Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. Behav Pharmacol 2004; 15(2): 149–157.

    Article  PubMed  CAS  Google Scholar 

  • Gable RS. Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction 2004; 99(6): 686.

    Article  PubMed  Google Scholar 

  • Gonzalez-Maeso J. et al. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 2007; 53(3): 439–452.

    Article  PubMed  CAS  Google Scholar 

  • Gouzoulis-Mayfrank E. et al. Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebocontrolled study. Psychopharmacology (Berl) 1999; 142(1): 41–50.

    Article  CAS  Google Scholar 

  • Gresch PJ. et al. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Neuropsychopharmacology 2005; 30(9): 1693–1702.

    Article  PubMed  CAS  Google Scholar 

  • Griffiths RR. et al, Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl) 2006; 187(3): 268–83; discus 284–92.

    Google Scholar 

  • Griffiths RR. et al, Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J Psychopharmacol 2008; in press.

    Google Scholar 

  • Grof S. The Effects of LSD on Chromosomes, Genetic Mutation, Fetal Development and Malignancy. In: LSD Psychotherapy. California: Hunter House Publishers; 1994.

    Google Scholar 

  • Halpern JH, Pope HG. Do hallucinogens cause residual neuropsychological toxicity? Drug Alcohol Depend 1999; 53(3): 247–256.

    Article  PubMed  CAS  Google Scholar 

  • Halpern JH, Pope HG. Hallucinogen persisting perception disorder: what do we know after 50 years? Drug Alcohol Depend 2003; 69(2): 109–119.

    Article  PubMed  Google Scholar 

  • Hasler F. et al. Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Psychopharmacology (Berl) 2004; 172(2): 145–146.

    Article  CAS  Google Scholar 

  • Hasler F. et al. Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man. J Pharm Biomed Anal 2002; 30(2): 331–339.

    Article  PubMed  CAS  Google Scholar 

  • Hillebrand J, Olszewski D, Sedefov R. Hallucinogenic mushrooms: an emerging trend case study, Papers ET., Editor. European Monitoring Centre for Drugs and Drug Addiction: Lissabon; 2006.

    Google Scholar 

  • Hofmann A. LSD: my problem child. MAPS; 2005.

    Google Scholar 

  • Isbell H. et al. Tolerance to diethylamide of lysergic acid (LSD-25). Fed Proc 1955; 14: 354.

    Google Scholar 

  • Korf DJ, Benschop A, Rots G. Geweld, alcohol en drugs bij jeugdige gedetineerden en school drop-outs. Tijdschrift voor Criminologie 2005; 47: 239–254.

    Google Scholar 

  • Korf D, Nabben T, Benschop A. Antenne 2003. Trend in alcohol, tabak en drugs bij jonge Amsterdammers. Amsterdam: Rozenberg Publishers; 2004.

    Google Scholar 

  • Lerner AG. et al. Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. Int Clin Psychopharmacol 2003; 18(2): 101–105.

    Article  PubMed  Google Scholar 

  • Li Z. et al. Stability study of LSD under various storage conditions. J Anal Toxicol 1998; 22(6): 520–525.

    PubMed  CAS  Google Scholar 

  • Meyer J, Quenzer L. Psychopharmacology. Drugs, the brain and behavior. Massachusetts: Sinauer Associates; 2005.

    Google Scholar 

  • Monshouwer K. et al. Jeugd en riskant gedrag: kerngegevens uit het peilstationsonderzoek 2003. Roken, drinken, drugsgebruik en gokken onder scholieren vanaf tien jaar. Utrecht: Trimbos Instituut; 2004.

    Google Scholar 

  • Moreno FA. et al. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry 2006; 67(11): 1735–1740.

    Article  PubMed  CAS  Google Scholar 

  • Nichols DE. Hallucinogens. Pharmacol Ther 2004; 101(2): 131–181.

    Article  PubMed  CAS  Google Scholar 

  • Ouwehand, AW. et al. Kerncijfers Verslavingszorg 2006. Houten: Landelijk Alcohol en Drugs Informatie Systeem (LADIS); 2007.

    Google Scholar 

  • Papac DI, Foltz RL. Measurement of lysergic acid diethylamide (LSD) in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. J Anal Toxicol 1990; 14(3): 189–190.

    PubMed  CAS  Google Scholar 

  • Passie T. et al. The pharmacology of psilocybin. Addict Biol 2002; 7(4): 357–364.

    Article  PubMed  CAS  Google Scholar 

  • Rodenburg G. et al. Nationaal Prevalentie Onderzoek Middelengebruik 2005. Rotterdam: IVO; 2007.

    Google Scholar 

  • Schultes R, Hofmann A. Over de planten der Goden. Oorsprong van het gebruik van hallucinogenen. Utrecht: Het Spectrum; 1997.

    Google Scholar 

  • Sewell RA, Halpern JH, Pope HG. Response of cluster headache to psilocybin and LSD. Neurology 2006; 66(12): 1920–1922.

    Article  PubMed  Google Scholar 

  • Snelders S, Kaplan C. LSD therapy in Dutch psychiatry: changing socio-political settings and medical sets. Med Hist 2002; 46(2): 221–240.

    PubMed  Google Scholar 

  • Stafford P. Psychedelics Encyclopedia. Berkeley: Ronin Publishing; 1992.

    Google Scholar 

  • Stone A. et al. Who is becoming hallucinogen dependent soon after hallucinogen use starts? Drug and Alcohol Dependence 2007; 87: 153–163.

    Article  PubMed  Google Scholar 

  • Vollenweider FX, Geyer MA. A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Res Bull 2001; 56(5): 495–507

    Article  PubMed  CAS  Google Scholar 

  • Vollenweider FX. et al. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 1998; 9(17): 3897–3902.

    Article  PubMed  CAS  Google Scholar 

  • Went GF van. Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and delta 9-THC, using the micronucleus test. Experientia 1978; 34(3): 324–325.

    Article  PubMed  Google Scholar 

  • Wittmann M. et al. Effects of psilocybin on time perception and temporal control of behaviour in humans. J Psychopharmacol 2007; 21(1): 50–64.

    Article  PubMed  CAS  Google Scholar 

  • Wouters M, Korf DJ. Wiet wijs: cannabisgebruik bij leerlingen in opvangprojecten en speciaal voortgezet onderwijs. Amsterdam: Rozenberg Publishers; 2004.

    Google Scholar 

Websites

Download references

Authors
  1. Hylke Vervaeke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Roel Kerssemakers Rob Van Meerten Els Noorlander Hylke Vervaeke

Copyright information

© 2008 Bohn Stafleu van Loghum

About this chapter

Cite this chapter

Vervaeke, H. (2008). Tripmiddelen: lsd en psychedelische paddenstoelen. In: Kerssemakers, R., Van Meerten, R., Noorlander, E., Vervaeke, H. (eds) Drugs en alcohol; Gebruik, misbruik en verslaving. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-6554-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-90-313-6554-8_11

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-313-5059-9

  • Online ISBN: 978-90-313-6554-8

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation